{"member_organisations": "", "identification_number": "27116427434-57", "fields_of_interest": "Economy, finance and the euro, Humanitarian aid and civil protection, Trade, Competition, Consumers, Customs, Enlargement, Business and Industry, Environment, Justice and Fundamental Rights, Single market, Research and innovation, External Relations, Public Health, Digital economy and society", "head_office_address": "PIET HEINKADE, 107", "full_time_equivalent_fte": "2,25", "person_with_legal_responsibility": "Richard Daniell", "industry_forums": "", "grants": "", "country_code": "nl", "inter_groups": "", "eu_initiatives": "Public Health, Industrial and IP Policies, Pricing and Reimbursement Policies, Pharmaceutical legislation, European external trade agenda, European semester, global health.", "level_of_interest": "European, global, national, regional/local", "organisation_name": "Teva Pharmaceuticals Europe BV (Teva)", "belgium_office_post_code": "1030", "number_of_persons_involved": "4", "person_in_charge_of_eu_relations": "Tyssier Erick", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": "4.9334573", "source": "", "subsection": "Companies & groups", "belgium_office_phone": "(+32)27390012", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "20 Square Vergote", "persons_accredited_for_access_to_european_parliament_premises": "TYSSIER #Erick , ZANAGLIO#Andrea", "registration_date": "14/12/2011", "estimate_of_costs_absolute_amount": "", "website_address": "http://www.tevapharm.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Amsterdam", "membership": "Medicines for Europe  \nEFPIA (as from September 2016) \nEUCOPE  \nFriends of Europe \nAECA \nEPF", "head_office_post_code": "1019", "position": "Senior Director Government Affairs and Public Policy", "financial_year_start_date": "01/01/2017", "head_office_country": "Netherlands", "number_of_ep_accredited_persons": "2", "relevant_communication": "- Sustainability, Quality and Access to healthcare systems  \n- eHealth / mHealth \n- Industrial policy Initiatives \n- Trade agreements  \n- IP measures  \n- Corporate social responsibility", "financial_year_end_date": "01/12/2017", "lat": "52.3725692", "estimate_of_costs_as_a_range": "600000-699999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "BV", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "Established in 1901, Teva is a global generic pharmaceuticals leader and one of the top 10 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide, of which more than 54,000 in the European Union. \n  \nTeva specializes in development, production and marketing of a wide range of generic and branded products, as well as active pharmaceutical ingredients (API).", "belgium_office_city": "Brussels", "head_office_phone": "(+31)0202193000"}